Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
ELITE PHARMACEUTICALS INC /NV/
| Metric | ELITE PHARMACEUTICALS INC /NV/ ELTPHealthcare |
|---|---|
| Quality Score | 60 / 100 |
| Revenue (latest) | $84M |
| Net income (latest) | −$4M |
| Operating margin | 23.3% |
| Net margin | −5.1% |
| Return on equity | −8.1% |
| Return on assets | −4.5% |
| Return on capital (ROCE) | 23.2% |
| Debt / equity | 0.80× |
| Revenue growth (YoY) | 48.4% |
| Altman Z″ (distress) | 1.72 |
| Accruals / assets | −12.2% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.